Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism MMPs inhibitors(Matrix metalloproteinase inhibitors), TFPI inhibitors(Tissue factor pathway inhibitor inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC24H25N3O5S |
InChIKeyRJUMZISZZHYKDC-HZHRSRAPSA-N |
CAS Registry402949-17-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | JP | - | |
Rheumatoid Arthritis | Discovery | JP | - |